Zobrazeno 1 - 10
of 276
pro vyhledávání: '"Michael A. Naughton"'
Autor:
Farrokh Dehdashti, Ningying Wu, Cynthia X. Ma, Michael J. Naughton, John A. Katzenellenbogen, Barry A. Siegel
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Clinical estrogen receptor (ER) testing for breast cancer is limited in predicting response to endocrine therapy (ET). In this phase 2 clinical trial, authors demonstrate that the responsiveness to ET can be predicted by use of PET/CT with 21-[18F]fl
Externí odkaz:
https://doaj.org/article/ff6d3e01875a44a08508cf739b64d668
Autor:
John T. Fourkas, Jinwei Gao, Zheng Han, Haitao Liu, Benedetta Marmiroli, Michael J. Naughton, John S. Petersen, Yong Sun, Alex Vagilio Pret, Yuebing Zheng
Publikováno v:
Frontiers in Nanotechnology, Vol 3 (2021)
Externí odkaz:
https://doaj.org/article/09351cb5a83c4960bdbb557f331d393f
Autor:
Paula M. Fracasso, Sherry A. Goodner, Jonathan D. Wildi, Michael J. Naughton, Gerald P. Linette, Ramaswamy Govindan, Benjamin R. Tan, Kristie A. Blum, Gary J. Jones, Tillman E. Pearce, Daniel J. Levitt, Gerald H. Clamon
Publikováno v:
Am J Clin Oncol
BACKGROUND: Human leukocyte antigen (HLA)-DR, a member of the major histocompatibility complex (MHC) class II antigen family, is a target for antibody-based therapeutics. Apolizumab (Hu1D10, Remitogen(™)), a humanized IgG1 monoclonal anti-HLA-DR ß
Autor:
Victoria R. Gabriele, Robabeh M. Mazhabi, Natalie Alexander, Purna Mukherjee, Thomas N. Seyfried, Njemuwa Nwaji, Eser M. Akinoglu, Andrzej Mackiewicz, Guofu Zhou, Michael Giersig, Michael J. Naughton, Krzysztof Kempa
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 965 (2021)
Melanin nanoparticles are known to be biologically benign to human cells for a wide range of concentrations in a high glucose culture nutrition. Here, we show cytotoxic behavior at high nanoparticle and low glucose concentrations, as well as at low n
Externí odkaz:
https://doaj.org/article/98bf935a41b04e1d91ed28ac288410b5
Autor:
John F. McVea, Michael J. Naughton
Publikováno v:
Religions, Vol 12, Iss 3, p 173 (2021)
In this paper, we propose that unreflective use of the term social entrepreneurship may perpetuate the idea that “entrepreneurship” is largely a financial and private reality and that this view of entrepreneurship will eventually trivialize or pe
Externí odkaz:
https://doaj.org/article/26f0eeb5950f47b4975d26af70df06a2
Autor:
James H. Doroshow, Richard M. Simon, Barbara A. Conley, Robert J. Kinders, P. Mickey Williams, Seth M. Steinberg, Paul M. McGregor, William D. Walsh, Michele G. Mehaffey, Chih-Jian Lih, Deborah E. Allen, Jiuping Ji, Alice P. Chen, Ahrim Youn, Peter M. Szabo, Robert J. Morgan, Miguel A. Villalona-Calero, Michael J. Naughton, David R. Gandara, Daniel M. Sullivan, Gini F. Fleming, Amit M. Oza, Shivaani Kummar
Supplemental Figure S2. PAR levels in patient PBMC samples. Data shown in dark red are from patients who reported deleterious BRCA mutations, data shown in dark blue are from patients reporting wildtype BRCA status, and data in grey are from patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46eb04a4b1e5f8c650779161c0112e8a
https://doi.org/10.1158/1078-0432.22461260.v1
https://doi.org/10.1158/1078-0432.22461260.v1
Autor:
James H. Doroshow, Richard M. Simon, Barbara A. Conley, Robert J. Kinders, P. Mickey Williams, Seth M. Steinberg, Paul M. McGregor, William D. Walsh, Michele G. Mehaffey, Chih-Jian Lih, Deborah E. Allen, Jiuping Ji, Alice P. Chen, Ahrim Youn, Peter M. Szabo, Robert J. Morgan, Miguel A. Villalona-Calero, Michael J. Naughton, David R. Gandara, Daniel M. Sullivan, Gini F. Fleming, Amit M. Oza, Shivaani Kummar
Supplementary Expression Data. Individual expression values for all 211 genes interrogated in the tumor tissue of 55 patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4719fdaa52cff5b2368e357113fb40cf
https://doi.org/10.1158/1078-0432.22461254
https://doi.org/10.1158/1078-0432.22461254
Autor:
Rebecca L. Aft, Timothy P. Fleming, Katherine N. Weilbaecher, Michael J. Naughton, William E. Gillanders, Kathryn M. Trinkaus, Lourdes R. Ylagan, Mark A. Watson
Purpose: Micrometastatic cells detected in the bone marrow have prognostic significance in breast cancer. These cells are heterogeneous and likely do not exhibit uniform biological behavior. To understand the molecular diversity of disseminated cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5ce37ea6c93cfe868a4410932032b5
https://doi.org/10.1158/1078-0432.c.6517510
https://doi.org/10.1158/1078-0432.c.6517510
Autor:
James H. Doroshow, Richard M. Simon, Barbara A. Conley, Robert J. Kinders, P. Mickey Williams, Seth M. Steinberg, Paul M. McGregor, William D. Walsh, Michele G. Mehaffey, Chih-Jian Lih, Deborah E. Allen, Jiuping Ji, Alice P. Chen, Ahrim Youn, Peter M. Szabo, Robert J. Morgan, Miguel A. Villalona-Calero, Michael J. Naughton, David R. Gandara, Daniel M. Sullivan, Gini F. Fleming, Amit M. Oza, Shivaani Kummar
Purpose: Veliparib, a PARP inhibitor, demonstrated clinical activity in combination with oral cyclophosphamide in patients with BRCA-mutant solid tumors in a phase I trial. To define the relative contribution of PARP inhibition to the observed clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a59e143b68831612282f14d975a5acd
https://doi.org/10.1158/1078-0432.c.6524744.v1
https://doi.org/10.1158/1078-0432.c.6524744.v1
Autor:
James H. Doroshow, Richard M. Simon, Barbara A. Conley, Robert J. Kinders, P. Mickey Williams, Seth M. Steinberg, Paul M. McGregor, William D. Walsh, Michele G. Mehaffey, Chih-Jian Lih, Deborah E. Allen, Jiuping Ji, Alice P. Chen, Ahrim Youn, Peter M. Szabo, Robert J. Morgan, Miguel A. Villalona-Calero, Michael J. Naughton, David R. Gandara, Daniel M. Sullivan, Gini F. Fleming, Amit M. Oza, Shivaani Kummar
Supplementary Methods, Tables S1 and S2, Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328021638afbe02d32a6d9991afde791
https://doi.org/10.1158/1078-0432.22461251
https://doi.org/10.1158/1078-0432.22461251